A randomized comparison between intravaginal misoprostol and prostaglandin E2 for labor induction

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine

Background:

• Labor induction is a common obstetric procedure.
• Prostaglandins are widely used for labor induction.
• Comparing different prostaglandin formulations is crucial for optimizing patient care.

Purpose of the Study:

• To compare the efficacy and safety of vaginal misoprostol versus vaginal prostaglandin E2 (PGE2) for labor induction.
• To evaluate side effects associated with each agent.

Main Methods:

• A randomized study involving 415 women.
• Vaginal misoprostol (50 mcg) or vaginal prostaglandin E2 (3 mg) administered every 6 hours (max 3 doses).
• Artificial rupture of membranes and oxytocin used as needed in both groups.

Main Results:

• The interval from induction to delivery was significantly shorter with misoprostol (11.3 h) compared to PGE2 (15.7 h).
• Misoprostol group required less oxytocin but showed higher tachysystole.
• No significant differences in abnormal fetal heart rate patterns, delivery mode, or neonatal intervention.

Conclusions:

• Intravaginal misoprostol (50 mcg every 6 hours) is more effective for labor induction than intravaginal PGE2 (3 mg).
• Misoprostol offers comparable safety to PGE2 for labor induction.
• Misoprostol is a viable alternative for labor induction.